Autologous platelet-rich-plasma injection and platelet-rich fibrin glue interposition for treatment of anal fistula resistant to surgery Regenerative medicine for anal fistula
Gastroenterology and Hepatology from Bed to Bench,
Vol. 16 No. 3 (2023),
3 June 2023
https://doi.org/10.22037/ghfbb.v16i2.2719
Abstract
Aim: The current study purposed to evaluate the autologous platelet-rich plasma (PRP), and platelet-rich fibrin glue (PRFG) effect on the treatment of complex, and recalcitrant anal fistula (AF) which was not cured by several surgeries.
Background: AF has remained one of difficult challenges for centuries. Surgery is the common treatment method for it, but the risk of fecal incontinence and recurrence is still a distressing complication for patients and surgeons. New procedures were published in the scientific literature, each with advantages and disadvantages. According to reports, an effective therapy option is the autologous fibrin glue that is rich in platelets.
Methods: Autologous PRP and PRFG were prepared from 10 patients’ own blood. The surgeon curetted the tract of anal fistula for the deepithelialisation till hemorrhage occurred; PRP was injected around the fistula into the tissue, and PRFG was interpositioned in the tract. Age, number of previous surgeries, complications, number of PRP and PRFG administrations, and duration of halting the discharge were among the information gathered. Patients were followed up between 10 months to 84 months after treatment.
Results: No complications were observed during and after the injection. During the period of follow-up, AF leakage was stopped for 6 patients, but not for 4 patients.
Conclusion: Since autologous PRP injection, and PRFG interposition is a safe, effective, and minimally invasive procedure for resistant AF to surgeries; it can be used, along with surgery to increase the healing rate of complex anal fistula.
- Anal Fistula, Platelet Rich Plasma, Fibrin Glue, Healing
How to Cite
References
Ji L, Zhang Y, Xu L, Wei J, Weng L, Jiang J. Advances in the treatment of anal fistula: a mini-review of recent five-year clinical studies. Front Surg 2021;7:586891.
García-Olmo D, Van Assche G, Tagarro I, Diez MC, Richard MP, Khalid JM, et al. Prevalence of anal fistulas in Europe: systematic literature reviews and population-based database analysis. Adv Ther 2019;36:3503-18.
Limura E, Giordano P. Modern management of anal fistula. World J Gastroenterol 2015;21:12-20.
Shirvan MK, Alamdar DH, Ghorifi A, Rahimi HR. A novel treatment for urethrovaginal fistula: autologous platelet-rich–plasma injection and platelet-rich–fibrin-glue interposition. J Gynecol Surg 2013;29:268-70.
van Onkelen RS, Gosselink MP, Thijsse S, Schouten WR. Predictors of outcome after transanal advancement flap repair for high transsphincteric fistulas. Dis Colon Rectum 2014;57:1007-11.
Van Koperen P, Ten Kate F, Bemelman W, Slors J. Histological identification of epithelium in perianal fistulae: a prospective study. Colorectal Dis 2010;12:891-5.
Lara FJP, Berges AF, Gonzalez JMH, Cardenas ES, del Rey Moreno A, Munoz HO. Method for management of perianal fistula with new device: Progressive curettage of the tract and sealing with platelet-rich fibrin. Ann Colorectal Res 2016;4:37452.
Vogel JD, Johnson EK, Morris AM, Paquette IM, Saclarides TJ, Feingold DL, et al. Clinical practice guideline for the management of anorectal abscess, fistula-in-ano, and rectovaginal fistula. Dis Colon Rectum 2016;59:1117-33.
Hjortrup A, Moesgaard F, Kjærgård J. Fibrin adhesive in the treatment of perineal fistulas. Dis Colon Rectum 1991;34:752-4.
Yeung J, Simpson J, Tang SW, Armitage N, Maxwell‐Armstrong C. Fibrin glue for the treatment of fistulae in ano–a method worth sticking to? Colorectal Dis 2010;12:363-6.
Moreno-Serrano A, García-Díaz JJ, Ferrer-Márquez M, Alarcón-Rodríguez R, Álvarez-García A, Reina-Duarte Á. Using autologous platelet-rich plasma for the treatment of complex fistulas. Rev Esp Enferm Dig 2016;108:123-8.
de la Portilla F, Muñoz-Cruzado MVD, Maestre MV, García-Cabrera AM, Reyes ML, Vázquez-Monchul JM, et al. Platelet-rich plasma (PRP) versus fibrin glue in cryptogenic fistula-in-ano: a phase III single-center, randomized, double-blind trial. Int J Colorectal Dis 2019;34:1113-9.
Lara F, Serrano AM, Moreno JU, Carmona JH, Marquez MF, Pérez LR, et al. Platelet-rich fibrin sealant as a treatment for complex perianal fistulas: a multicentre study. J Gastrointest Surg 2015;19:360-8.
Pérez Lara FJ, Hernández González JM, Ferrer Berges A, Navarro Gallego I, Oehling de los Reyes H, Oliva Muñoz H. Can Perianal fistula be treated non-surgically with platelet-rich fibrin sealant? J Gastrointest Surg 2019;23:1030-6.
Van der Hagen S, Baeten C, Soeters P, Van Gemert W. Autologous platelet‐derived growth factors (platelet‐rich plasma) as an adjunct to mucosal advancement flap in high cryptoglandular perianal fistulae: a pilot study. Colorectal Dis 2011;13:215-8.
Wilkinson HN, Hardman MJ. Wound healing: cellular mechanisms and pathological outcomes. Open Biol 2020;10:200223.
Laurens N, Koolwijk Pd, De Maat M. Fibrin structure and wound healing. J Thromb Haemost 2006;4:932-9.
Spotnitz WD. Commercial fibrin sealants in surgical care. Am J Surg 2001;182:8-14.
Burnouf T, Goubran HA, Chen T-M, Ou K-L, El-Ekiaby M, Radosevic M. Blood-derived biomaterials and platelet growth factors in regenerative medicine. Blood Rev 2013;27:77-89.
Feng M, Wang Y, Zhang P, Zhao Q, Yu S, Shen K, et al. Antibacterial effects of platelet-rich fibrin produced by horizontal centrifugation. Int J Oral Sci 2020;12:32.
- Abstract Viewed: 253 times
- PDF Downloaded: 184 times